DNA Polymerase Market - Top Companies and Manufacturers

  • Report ID: 6423
  • Published Date: Sep 12, 2024
  • Report Format: PDF, PPT

Companies Dominating the DNA Polymerase Landscape

    The DNA polymerase market is highly concentrated worldwide, with major biopharmaceutical companies controlling a sizable portion of the market. Major industry participants are investigating new applications in compliance with local, state, federal, and global regulatory norms, and concentrating more on product research and launch.

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Hoffman-La Roche AG
    • Merck KGaA
    • Qiagen N.V.
    • Agilent Technologies Inc.
    • Takara Bio Inc.
    • GenScript Biotech Corporation
    • Illumine Inc.
    • Promega Corporation
    • New England Biolabs, inc.

Browse Key Market Insights with Data Illustration:

In the News

  • In July 2022, Thermo Fisher Scientific, the world leader in science services, released the Applied Biosystems TaqPath Respiratory Viral Select Panel, a CE-IVD-marked molecular assay panel for detecting five common viruses, including those that cause the common cold, bronchiolitis, croup, influenza-like illnesses, and pneumonia.
  • In November 2021, QIAGEN added StableScript to their OEM offering. The versatile reverse transcriptase is available in bulk quantities and is suitable for one-step RT-qPCR and long-range RT-PCR applications. The discovery of reverse transcriptases made it possible to apply polymerase chain reaction (PCR) to RNA and create cDNA libraries from mRNA. Commercial availability has facilitated RNA cloning, sequencing, and characterization.

Author Credits:  Radhika Pawar


  • Report ID: 6423
  • Published Date: Sep 12, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of DNA polymerase was over USD 348.9 million.

The market size for DNA polymerase is projected to cross USD 762.6 million by the end of 2037 expanding at a CAGR of 6.2% during the forecast period i.e., between 2025-2037.

The major players in the market are Thermo Fisher Scientific Inc., Hoffman-La Roche AG, Merck KGaA, Qiagen N.V., Agilent Technologies Inc., Takara Bio Inc., GenScript Biotech Corporation, Illumine Inc., Promega Corporation, New England Biolabs, Inc., and others.

The taq polymerase segment is anticipated to garner a size of 50.3% during 2025-2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample